表紙
市場調查報告書

美國的肥胖外科手術用設備市場預測

United States Bariatric Surgery Devices Market Outlook to 2025 - Gastric Balloons and Gastric Bands

出版商 GlobalData 商品編碼 307140
出版日期 內容資訊 英文 63 Pages
訂單完成後即時交付
價格
美國的肥胖外科手術用設備市場預測 United States Bariatric Surgery Devices Market Outlook to 2025 - Gastric Balloons and Gastric Bands
出版日期: 2020年09月30日內容資訊: 英文 63 Pages
簡介

本報告提供美國的肥胖外科手術用設備市場相關的減重手術用縫合器,胃束帶,胃水球等類別銷售額,銷售數的實際成果及預測,平均價格,企業佔有率,流通佔有率,再加上主要企業簡介,開發中產品,主要的財務相關交易之最新資訊等資料。

第1章 目錄

第2章 簡介

  • 報告的內容
  • 肥胖外科手術用設備市場區分
  • 該報告對象的市場定義

第3章 美國的肥胖外科手術用設備市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 主要企業概要

  • Covidien plc
  • Ethicon Endo-Surgery, Inc.
  • Allergan, Inc.

第5章 開發中產品

第6章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECC5361DB

GlobalData's "United States Bariatric Surgery Devices Market Outlook to 2025" is a comprehensive databook report, covering key market data on the United States Bariatric Surgery Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Gastric Balloons and Gastric Bands.

The United States Bariatric Surgery Devices Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2019 company share and distribution share data for Bariatric Surgery Devices Market.
  • Global corporate-level profiles of key companies operating within the United States Bariatric Surgery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Bariatric Surgery Devices is segmented as follows -

  • Gastric Balloons
  • Gastric Bands

Reasons to Buy

The United States Bariatric Surgery Devices Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Bariatric Surgery Devices Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Bariatric Surgery Devices Market, United States

  • 3.1 Bariatric Surgery Devices Market, United States, Revenue ($m), 2015-2025
  • 3.2 Bariatric Surgery Devices Market, United States, Volume (Units), 2015-2025
  • 3.3 Bariatric Surgery Devices Market, United States, Average Price ($), 2015-2025
  • 3.4 Bariatric Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2019
  • 3.5 Bariatric Surgery Devices Market, United States, Company Share by Revenue ($m), 2019

4 Overview of Key Companies in United States, Bariatric Surgery Devices Market

  • 4.1 ReShape Lifesciences Inc
    • 4.1.1 Company Overview
  • 4.2 Obalon Therapeutics Inc
    • 4.2.1 Company Overview
  • 4.3 Apollo Endosurgery Inc
    • 4.3.1 Company Overview

5 Bariatric Surgery Devices Market Pipeline Products

6 Financial Deals Landscape

  • 6.1 Debt Offerings
    • 6.1.1 Boston Scientific Raises USD1.2 Billion in Public Offering of 2.65% Senior Notes due 2030
    • 6.1.2 Boston Scientific Raises USD500 Million in Public Offering of 1.9% Senior Notes due 2025
    • 6.1.3 Boston Scientific Raises USD999.2 Million in Public Offering of 0.625% Notes Due 2027
    • 6.1.4 GI Dynamics to up to Raise USD4.6 Million in Private Placement of Convertible Note and Warrant
    • 6.1.5 Apollo Endosurgery Raises USD20 Million in Private Placement of 6% Convertible Debentures Due 2024
  • 6.2 Equity Offerings
    • 6.2.1 Boston Scientific Raises USD1 Billion in Public Offering of Shares
    • 6.2.2 Boston Scientific Raises USD1 Billion in Public Offering of 5.5% Mandatory Convertible Preferred Stock
    • 6.2.3 Drive DeVilbiss Healthcare Raises USD35 Million in Financing Round
    • 6.2.4 GI Dynamics Raises USD2 Million in First Tranche of Private Placement of CHESS Depositary Interests, upon Exercise of Warrants
    • 6.2.5 ReShape Lifesciences to Raise USD8 Million in Private Placement of Common Stock
  • 6.3 Private Equity
    • 6.3.1 Obalon Therapeutics to Raise up to USD15 Million in Financing
    • 6.3.2 Gelesis Raises USD63.4 Million in Financing

7 Recent Developments

  • 7.1 Corporate Communications
    • 7.1.1 Dec 16, 2019: Jean-Claude Dubacher named Chairman and Chief Executive Officer of B. Braun Medical
    • 7.1.2 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform
    • 7.1.3 Nov 20, 2019: GI Dynamics: Appointment of an Observer to the Board of Directors Representing Crystal Amber
    • 7.1.4 Nov 03, 2019: Saint Barnabas Medical Center names new Vice President of Operations
    • 7.1.5 Oct 30, 2019: ReShape Lifesciences appoints Thomas Stankovich as Chief Financial Officer
    • 7.1.6 Oct 24, 2019: Obalon appoints William J. Plovanic as Chief Executive Officer and Nooshin Hussainy as Chief Financial Officer
    • 7.1.7 Oct 24, 2019: Saint Barnabas Medical Center appoints New Chief Nursing Officer
    • 7.1.8 Sep 03, 2019: Obalon engages Helmuth T. Billy, MD as Medical Director for its first company-owned weight loss treatment center
    • 7.1.9 Aug 06, 2019: ReShape Lifesciences announces CFO resignation
    • 7.1.10 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health
    • 7.1.11 Jun 27, 2019: TriSalus Life Sciences forms world-class scientific advisory board to accelerate advancement of strategy to deliver therapeutics to solid tumors
  • 7.2 Financial Announcements
    • 7.2.1 Feb 27, 2020: Obalon announces fourth quarter and full year 2019 financial results
    • 7.2.2 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
    • 7.2.3 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
    • 7.2.4 Nov 14, 2019: ReShape Lifesciences announces third quarter 2019 financial results
    • 7.2.5 Nov 08, 2019: Obalon announces third quarter 2019 financial results
    • 7.2.6 Oct 30, 2019: Apollo Endosurgery reports third quarter 2019 results
    • 7.2.7 Oct 23, 2019: Boston Scientific announces results for third quarter 2019
    • 7.2.8 Jul 24, 2019: Boston Scientific announces results for second quarter 2019
    • 7.2.9 Jul 24, 2019: Obalon announces second quarter 2019 financial results
    • 7.2.10 Jul 23, 2019: Apollo Endosurgery reports second quarter 2019 results
  • 7.3 Government and Public Interest
    • 7.3.1 Sep 05, 2019: FDA solicits public feedback on discussion paper as part of efforts to provide clarity and transparency on how it evaluates benefits and risks of weight-loss devices
  • 7.4 Other Significant Developments
    • 7.4.1 May 11, 2020: Obalon announces further impacts related to covid-19 crisis and current business environment
    • 7.4.2 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
    • 7.4.3 Feb 24, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan notes
    • 7.4.4 Jan 07, 2020: Jant Pharmacal is awarded contract from Vizient
    • 7.4.5 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica
    • 7.4.6 Jul 31, 2019: GI Dynamics: Quarter Ended 30 June 2019
    • 7.4.7 Jul 01, 2019: Vizient announces 26 new, renewed or expanded member agreements in Q1 of 2019
  • 7.5 Product News
    • 7.5.1 Feb 04, 2020: Vizient to participate in FI HFMA & CHEF's 2020 Managed Care Symposium
  • 7.6 Strategy And Business Planning
    • 7.6.1 Feb 12, 2020: Sanford announces new Bemidji heart center
    • 7.6.2 Jun 24, 2019: Boston Scientific Galway expands in to new facility

8 Appendix

  • 8.1 Research Methodology
    • 8.1.1 Coverage
    • 8.1.2 Secondary Research
    • 8.1.3 Primary Research
    • 8.1.4 Market Modeling and Forecasting
    • 8.1.5 Company Share Analysis
    • 8.1.6 Distribution Share Analysis
    • 8.1.7 Benchmarking
  • 8.2 GlobalData Consulting
  • 8.3 Contact Us
  • 8.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
  • Table 2: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
  • Table 3: Bariatric Surgery Devices Market, Unite

List of Figures

List of Figures

  • Figure 1: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
  • Figure 2: Bariatric Surgery Devices Market, United States, Volume (Units), 2015-2025
  • Figure 3: Bariatric Surgery Devices Market, United States, Company Share (%) 2019